Treatment of Indian visceral leishmaniasis with single or daily infusions of low dose liposomal amphotericin B: randomised trial
AUTOR(ES)
Sundar, Shyam
FONTE
BMJ Group
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=37549Documentos Relacionados
- Immunoenhancement Combined with Amphotericin B as Treatment for Experimental Visceral Leishmaniasis
- Treatment of Experimental Visceral Leishmaniasis with Amphotericin B in Stable Albumin Microspheres
- Activity of liposomal amphotericin B against experimental cutaneous leishmaniasis.
- Combination therapy with liposomal amphotericin b (ambisome), n-methylglucamine antimoniate (glucantime), and pentamidine isethionate in a refractory visceral leishmaniasis case
- Single-Dose AmBisome (Liposomal Amphotericin B) as Prophylaxis for Murine Systemic Candidiasis and Histoplasmosis